Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate and Infliximab Combination in Ankylosing Spondylitis
NCT00432432Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Feb 2005
- Primary completion
- Aug 2006
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, double-blind trial in ankylosing spondylitis (AS) comparing Methotrexate + Infliximab with Placebo + Infliximab (2 arms). Primary endpoint: Assessment of SpondyloArthritis international Society 20 response at 20 weeks. Started Feb 2005; status: completed.
02
Drugs
methotrexate
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00432432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432432.